Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph early_phase_1
1
25%
Ph phase_3
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

completed125%
unknown250%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Efficacy of Remifentanil in Preventing Emergence Agitation

NCT06539013
unknownnot_applicable

Effect of Acute Treatment With N2O on Inhibitory Pain Mechanisms in Healthy Subject

NCT01616004
unknownearly_phase_1

The Effect of N2O on Chronic Neuropathic Pain Patients

NCT02246517
completedphase_3

Inhaled Nitrous Oxide for Pain Relief During Eye Exam in the Pre-term Infant

NCT00623220

Clinical Trials (4)

Showing 4 of 4 trials
NCT06539013Not Applicable

Efficacy of Remifentanil in Preventing Emergence Agitation

Recruiting
NCT01616004Not Applicable

Effect of Acute Treatment With N2O on Inhibitory Pain Mechanisms in Healthy Subject

Unknown
NCT02246517Early Phase 1

The Effect of N2O on Chronic Neuropathic Pain Patients

Unknown
NCT00623220Phase 3

Inhaled Nitrous Oxide for Pain Relief During Eye Exam in the Pre-term Infant

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4